Table 2 Clinical and immunophenotypic... | American Society of Hematology

Table 2

Clinical and immunophenotypic features of age-related EBV LPD tumors

No.	Age, y	Sex	Biopsy specimen	CD15	CD20	CD30	CD45	CD79a	EBER	LMP1	EBNA2
1	79	M	Skin	0	2+	2+	1+	2+	2+	1+	2+
2	82	M	Cervical LN	0	2+	2+	0	2+	2+	2+	2+
3	88	M	Cervical LN	0	2+	0	0	2+	2+	2+	0
4	79	F	Skin	0	2+	1+	1+	2+	2+	2+	0
5	63	F	Lung, stomach	0	2+	0	0	2+	2+	2+	2+
6	73	F	Skin, LN	0	2+	2+	0	2+	2+	2+	0
7	83	M	Pharynx	0	2+			2+	2+	2+	0
8	68	M	LN	0	2+	0	0	2+	2+	2+	0
9	85	M	LN	0	2+	0	0	2+	2+	2+	0
10	78	M	Spleen	0	2+	0	1+	2+	2+	2+	2+
11	78	F	LN	0	NS	0	2+	2+	2+	2+	2+
12	71	F	LN	0	2+	0	0	2+	2+	2+	0
13	70	F	Stomach		2+				2+	2+	0
14	64	F	LN	0	2+	1+			2+	2+	0
15	67	F	LN	0	2+	1+			2+	2+	0
16	63	F	Tonsil	0	2+	1+		2+	2+	2+	0
17	50	M	Stomach	0	2+	2+			2+
18	68	M	LN	0	2+	1+			2+	2+	0
19	65	F	LN	0	2+	2+			2+	2+	0
20	81	F	LN	0	2+	1+	0	2+	2+
21	71	F	LN	0	2+	1+			2+	1+	0
22	86	M	Nasal cavity	0	2+	0		2+	2+	1+	2+
23	78	M	LN		2+	2+			2+	2+	0
24	63	M	LN	0	2+	2+			2+	2+	0
25	54	M	LN	0	2+	2+			2+	2+	0
26	55	F	Tonsil	0	2+	2+		2+	2+	2+	2+
27	73	M	LN		2+				2+
28	61	F	Skin	0	2+	1+			2+	2+	0
29	55	M	LN		2+				2+
30	71	M	LN		2+			2+	2+	2+	NS
31	79	M	LN		2+				2+
32	74	M	Media-LN	0	2+	2+		0	2+	2+	NS
33	66	M	LN		2+			2+	2+	2+
34	82	M	LN	0	NS	2+		2+	2+	2+	0

No.	Age, y	Sex	Biopsy specimen	CD15	CD20	CD30	CD45	CD79a	EBER	LMP1	EBNA2
1	79	M	Skin	0	2+	2+	1+	2+	2+	1+	2+
2	82	M	Cervical LN	0	2+	2+	0	2+	2+	2+	2+
3	88	M	Cervical LN	0	2+	0	0	2+	2+	2+	0
4	79	F	Skin	0	2+	1+	1+	2+	2+	2+	0
5	63	F	Lung, stomach	0	2+	0	0	2+	2+	2+	2+
6	73	F	Skin, LN	0	2+	2+	0	2+	2+	2+	0
7	83	M	Pharynx	0	2+			2+	2+	2+	0
8	68	M	LN	0	2+	0	0	2+	2+	2+	0
9	85	M	LN	0	2+	0	0	2+	2+	2+	0
10	78	M	Spleen	0	2+	0	1+	2+	2+	2+	2+
11	78	F	LN	0	NS	0	2+	2+	2+	2+	2+
12	71	F	LN	0	2+	0	0	2+	2+	2+	0
13	70	F	Stomach		2+				2+	2+	0
14	64	F	LN	0	2+	1+			2+	2+	0
15	67	F	LN	0	2+	1+			2+	2+	0
16	63	F	Tonsil	0	2+	1+		2+	2+	2+	0
17	50	M	Stomach	0	2+	2+			2+
18	68	M	LN	0	2+	1+			2+	2+	0
19	65	F	LN	0	2+	2+			2+	2+	0
20	81	F	LN	0	2+	1+	0	2+	2+
21	71	F	LN	0	2+	1+			2+	1+	0
22	86	M	Nasal cavity	0	2+	0		2+	2+	1+	2+
23	78	M	LN		2+	2+			2+	2+	0
24	63	M	LN	0	2+	2+			2+	2+	0
25	54	M	LN	0	2+	2+			2+	2+	0
26	55	F	Tonsil	0	2+	2+		2+	2+	2+	2+
27	73	M	LN		2+				2+
28	61	F	Skin	0	2+	1+			2+	2+	0
29	55	M	LN		2+				2+
30	71	M	LN		2+			2+	2+	2+	NS
31	79	M	LN		2+				2+
32	74	M	Media-LN	0	2+	2+		0	2+	2+	NS
33	66	M	LN		2+			2+	2+	2+
34	82	M	LN	0	NS	2+		2+	2+	2+	0

Scoring for the expression of immunophenotypic markers: 0 indicates a negative stain; 1+, positive on less than 50% of tumor cells; and 2+, positive on more than 50%.

LPD indicates lymphoproliferative disorder; LN, lymph node; and NS, not satisfactory.

View Large

This Feature Is Available To Subscribers Only